Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Biomedical Advanced Research & Development Authority (BARDA) Accelerator Network Collaborative Virtual Series
Event | 07. 01. 2022
Art Pappas will be participating in BARDA's Accelerator Network Collaborative Virtual Series panel discussion titled "Scale your Company via Strategic Partnerships & Venture Financing" on July 1st from 12:00-1:30 PM EDT.
